AskTheDate.com
Back to calendar

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

SUPN reports earnings on Monday, August 3, 2026

earnings report
August 3, 2026
Q2 2026
Est. EPS: $0.68
Actual EPS: $0.53
EPS surprise: 24.51%
Company overview
Market Cap$2.7B
PriceUSD 46.00
EPS (TTM)-1.91
52-week high59.68
52-week low36.46
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees778